Specifically, our studies in both humans and mice suggest that ID1/Id1, a direct target of OVOL1/Ovol1 transcriptional repression in keratinocytes, plays a role in promoting AD-associated epidermal hyperplasia, barrier disruption, and clinical symptoms. The gene discussed is OVOL1; the disease is Alzheimer disease.